Literature DB >> 10334726

Prevention of corticosteroid induced osteoporosis.

P Lips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10334726      PMCID： PMC1115759          DOI： 10.1136/bmj.318.7195.1366

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.

Authors:  R Eastell; D M Reid; J Compston; C Cooper; I Fogelman; R M Francis; D J Hosking; D W Purdie; S H Ralston; J Reeve; R G Russell; J C Stevenson; D J Torgerson
Journal:  J Intern Med       Date:  1998-10       Impact factor: 8.989

Review 2.  Clinical review 83: Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis.

Authors:  E Canalis
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

3.  Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study.

Authors:  L J Walsh; C A Wong; M Pringle; A E Tattersfield
Journal:  BMJ       Date:  1996-08-10

4.  Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.

Authors:  P Sambrook; J Birmingham; P Kelly; S Kempler; T Nguyen; N Pocock; J Eisman
Journal:  N Engl J Med       Date:  1993-06-17       Impact factor: 91.245

5.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

6.  Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids.

Authors:  G M Hall; M Daniels; D V Doyle; T D Spector
Journal:  Arthritis Rheum       Date:  1994-10

7.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Authors:  J D Adachi; W G Bensen; J Brown; D Hanley; A Hodsman; R Josse; D L Kendler; B Lentle; W Olszynski; L G Ste-Marie; A Tenenhouse; A A Chines
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

8.  Testosterone therapy in glucocorticoid-treated men.

Authors:  I R Reid; D J Wattie; M C Evans; J P Stapleton
Journal:  Arch Intern Med       Date:  1996-06-10
  8 in total
  2 in total

1.  Use of guidelines should be evaluated in randomised controlled trials.

Authors:  J R Kirwan
Journal:  BMJ       Date:  1999-09-04

2.  Measurement equivalence of osteoporosis-specific and general quality-of-life instruments in Aboriginal and non-Aboriginal women.

Authors:  Lisa M Lix; Colleen Metge; William D Leslie
Journal:  Qual Life Res       Date:  2009-03-29       Impact factor: 4.147
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.